17-section deep analysis covering fundamentals, technicals, Wall Street ratings, sentiment, and proprietary scoring. The same depth a sell-side analyst delivers — on demand.
First 100 subscribers get 50% off for 3 months.
No spam — one launch announcement and one welcome offer.
From confidence scoring and fundamental scorecard through to bull/bear case, insider transactions, sector relative strength, and final verdict with position sizing.
Fundamentals (45%), Risk (20%), Technicals (20%), Sentiment & Catalysts (15%) — weighted into a 0-100 confidence score with explicit rating bands.
From ticker entry to PDF download in under 90 seconds. Real-time market data, current analyst ratings, latest earnings — fetched at request time.
We don't apply P/E ratios to pre-revenue biotechs. We don't ignore Altman Z-Score on distressed firms. Each report auto-detects company stage and scores accordingly.